首页 > 最新文献

Journal of Heart and Lung Transplantation最新文献

英文 中文
Randomized evaluation of comparative effects of optimized static cold storage, hypothermic and normothermic machine perfusion, and colchicine pretreatment on ischemia-reperfusion injury in a porcine model. 心脏移植保存的随机评价:优化静态冷藏、低温和恒温机器灌注和秋水仙碱预处理对猪模型缺血-再灌注损伤的比较效果。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.healun.2025.12.023
Aurore Ughetto, Clément Delmas, Lison Benezech, Pascal Battistella, Philippe Gaudard, Adrien Molina, Guillaume Andre, Soumaya Maamar, Julien Guihaire, Rachel Audo, M Carmen Martinez, Celine Guilbeau-Frugier, Demaria Roland, Fanchon Herman, Alain Lacampagne, François Roubille

Background: Heart transplantation remains limited by ischemia-reperfusion injury (IRI). Optimizing graft preservation and modulating inflammation may improve early graft quality. We compared optimized static cold storage (SCS), hypothermic machine perfusion (HMP), and normothermic machine perfusion (NMP), and evaluated colchicine pretreatment as an adjunct anti-inflammatory strategy.

Methods: Thirty-six pigs were randomized to colchicine or placebo (n=18 each) and subsequently assigned to SCS, HMP, or NMP (n=12 per group). After 4 h of preservation, all hearts underwent 1 h of normothermic reperfusion. Myocardial injury, lactate extraction, systemic cytokines, and histological assessments were performed. Mixed-effects models accounting for repeated measures and treatment-preservation interactions were used for all longitudinal analyses.

Results: HMP was associated with lower H-FABP levels than SCS (β -92.6; 95% CI -183 to -2.6; p=0.04), while NMP showed no difference. Troponin I release was significantly higher in NMP versus SCS (β 97.9; 95% CI 63.4-132; p<0.001). Lactate extraction was greater with HMP compared with SCS (β 10.2; 95% CI -0.2 to 20.6; p=0.05), with no difference for NMP. Preservation modality strongly influenced inflammation: IL-6 (β 3.72; p<0.001) and TNF-α (β 0.25; p=0.003) were markedly increased in NMP, whereas IL-10 was reduced in HMP versus SCS (β -0.38; p<0.001). Colchicine had no significant effect on any biomarker. Oxidative stress proteins, apoptosis markers, and histological injury scores did not differ across preservation modalities or treatment groups.

Conclusions: In this randomized large-animal model, hypothermic preservation (SCS, HMP) provides superior metabolic and inflammatory profiles compared with NMP. Colchicine did not confer additional benefit under these conditions.

背景:心脏移植仍然受到缺血再灌注损伤(IRI)的限制。优化移植物保存和调节炎症可改善早期移植物质量。我们比较了优化的静态冷藏(SCS)、低温机器灌注(HMP)和恒温机器灌注(NMP),并评估了秋水仙碱预处理作为辅助抗炎策略。方法:36头猪随机分为秋水仙碱组和安慰剂组(每组18只),随后分为SCS组、HMP组和NMP组(每组12只)。保存4小时后,所有心脏进行1小时常温再灌注。进行心肌损伤、乳酸提取、全身细胞因子和组织学评估。所有的纵向分析都使用了考虑重复测量和处理-保存相互作用的混合效应模型。结果:HMP组H-FABP水平低于SCS组(β -92.6; 95% CI -183 ~ -2.6; p=0.04),而NMP组无差异。结论:在这个随机的大型动物模型中,低温保存(SCS, HMP)与NMP相比提供了更好的代谢和炎症特征。秋水仙碱在这些条件下没有额外的益处。
{"title":"Randomized evaluation of comparative effects of optimized static cold storage, hypothermic and normothermic machine perfusion, and colchicine pretreatment on ischemia-reperfusion injury in a porcine model.","authors":"Aurore Ughetto, Clément Delmas, Lison Benezech, Pascal Battistella, Philippe Gaudard, Adrien Molina, Guillaume Andre, Soumaya Maamar, Julien Guihaire, Rachel Audo, M Carmen Martinez, Celine Guilbeau-Frugier, Demaria Roland, Fanchon Herman, Alain Lacampagne, François Roubille","doi":"10.1016/j.healun.2025.12.023","DOIUrl":"10.1016/j.healun.2025.12.023","url":null,"abstract":"<p><strong>Background: </strong>Heart transplantation remains limited by ischemia-reperfusion injury (IRI). Optimizing graft preservation and modulating inflammation may improve early graft quality. We compared optimized static cold storage (SCS), hypothermic machine perfusion (HMP), and normothermic machine perfusion (NMP), and evaluated colchicine pretreatment as an adjunct anti-inflammatory strategy.</p><p><strong>Methods: </strong>Thirty-six pigs were randomized to colchicine or placebo (n=18 each) and subsequently assigned to SCS, HMP, or NMP (n=12 per group). After 4 h of preservation, all hearts underwent 1 h of normothermic reperfusion. Myocardial injury, lactate extraction, systemic cytokines, and histological assessments were performed. Mixed-effects models accounting for repeated measures and treatment-preservation interactions were used for all longitudinal analyses.</p><p><strong>Results: </strong>HMP was associated with lower H-FABP levels than SCS (β -92.6; 95% CI -183 to -2.6; p=0.04), while NMP showed no difference. Troponin I release was significantly higher in NMP versus SCS (β 97.9; 95% CI 63.4-132; p<0.001). Lactate extraction was greater with HMP compared with SCS (β 10.2; 95% CI -0.2 to 20.6; p=0.05), with no difference for NMP. Preservation modality strongly influenced inflammation: IL-6 (β 3.72; p<0.001) and TNF-α (β 0.25; p=0.003) were markedly increased in NMP, whereas IL-10 was reduced in HMP versus SCS (β -0.38; p<0.001). Colchicine had no significant effect on any biomarker. Oxidative stress proteins, apoptosis markers, and histological injury scores did not differ across preservation modalities or treatment groups.</p><p><strong>Conclusions: </strong>In this randomized large-animal model, hypothermic preservation (SCS, HMP) provides superior metabolic and inflammatory profiles compared with NMP. Colchicine did not confer additional benefit under these conditions.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145889190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiologist- and computer-based chest imaging quantification at 12 months post transplant correlates with baseline lung allograft dysfunction. 移植后12个月的放射科医生和基于计算机的胸部成像量化与基线同种异体肺移植功能障碍相关。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.healun.2025.12.018
Mikail Malik, Gauri Rani Karur, Apoorva Muralidhar, Nour Hanafi, Anastasiia Vasileva, Joyce K Y Wu, Ella Huszti, Tereza Martinu, Chung-Wai Chow, Micheal C McInnis

Background: Baseline lung allograft dysfunction (BLAD), defined as failure to achieve ≥ 80% predicted spirometry after lung transplant, is associated with reduced survival. This study aimed to determine the prevalence and character of computed tomography (CT) abnormalities in BLAD.

Methods: In this retrospective cohort study, we analyzed adult first-time double-lung transplant recipients (12/2017-10/2021) who had 12-month CT chest and concurrent BLAD/non-BLAD status assigned. Three radiologists used a semi-quantitative ordinal score to evaluate ground glass opacities (GGO), reticulation, consolidation, pleural effusion, bronchiectasis, and air-trapping. Machine learning-trained lung texture analysis provided CT radiomic data: CT-measured total lung capacity (CTTLC), pulmonary vessel volume (PVV), GGO, reticulation, and hyperlucency. Parametric response mapping measured functional small airways disease. Receiver operating characteristic analysis and logistic regression identified radiologic features of BLAD.

Results: BLAD patients (n = 59, 46%) had longer intubation duration, longer index hospitalization post-transplant, and lower donor-to-recipient total lung capacity (TLC) ratio than non-BLAD patients (n = 69, 54%). Radiologist-assessed scoring identified more pleural effusions in BLAD with no significant differences in GGO or air trapping. Computer-aided CT demonstrated more reticulation, GGO, and parenchymal density in BLAD, with no difference in functional small airways disease. CTTLC indexed for height was lower in BLAD, while PVV was higher. PVV was significantly associated with BLAD in univariable analysis (OR 2.30, 95% CI 1.38-3.83, p < 0.001), and remained strong after adjusting for age, sex, and native disease (OR = 2.65,95% CI 1.45-4.84, p = 0.002).

Conclusions: Computer-aided CT elicited structural changes in BLAD not captured by limited-slice radiologist review. CTTLC and PVV were the strongest radiologic predictors of BLAD, likely reflecting restrictive physiology and vascular remodeling.

背景:基线肺同种异体移植功能障碍(BLAD),定义为肺移植后肺活量未能达到≥80%预测值,与生存率降低相关。本研究旨在确定BLAD中计算机断层扫描(CT)异常的患病率和特征。方法:在这项回顾性队列研究中,我们分析了成人首次双肺移植受者(2017年12月至2021年10月),他们接受了12个月的胸部CT检查,并同时确定了BLAD/非BLAD状态。三位放射科医生使用半定量序数评分来评估磨玻璃混浊(GGO)、网状、实变、胸腔积液、支气管扩张和空气潴留。机器学习训练的肺结构分析提供了CT放射学数据:CT测量的总肺活量(CTTLC)、肺血管容积(PVV)、GGO、网状结构和高通透性。参数化反应映射测量功能性小气道疾病。ROC分析和logistic回归确定了BLAD的放射学特征。结果:与非BLAD患者相比,BLAD患者(n=59, 46%)插管时间更长,移植后指数住院时间更长,供受体总肺容量(TLC)比更低(n=69, 54%)。放射科医师评估的评分显示,BLAD患者胸膜积液较多,而GGO或空气潴留无显著差异。计算机辅助CT显示BLAD有更多的网状、GGO和实质密度,在功能性小气道疾病中无差异。BLAD患者CTTLC的高度指数较低,而PVV的高度指数较高。在单变量分析中,PVV与BLAD显著相关(OR 2.30, 95% CI 1.38-3.83)。结论:计算机辅助CT引起的BLAD的结构改变未被有限层放射科医师复查捕获。CTTLC和PVV是BLAD最强的放射学预测因子,可能反映了限制性生理和血管重构。
{"title":"Radiologist- and computer-based chest imaging quantification at 12 months post transplant correlates with baseline lung allograft dysfunction.","authors":"Mikail Malik, Gauri Rani Karur, Apoorva Muralidhar, Nour Hanafi, Anastasiia Vasileva, Joyce K Y Wu, Ella Huszti, Tereza Martinu, Chung-Wai Chow, Micheal C McInnis","doi":"10.1016/j.healun.2025.12.018","DOIUrl":"10.1016/j.healun.2025.12.018","url":null,"abstract":"<p><strong>Background: </strong>Baseline lung allograft dysfunction (BLAD), defined as failure to achieve ≥ 80% predicted spirometry after lung transplant, is associated with reduced survival. This study aimed to determine the prevalence and character of computed tomography (CT) abnormalities in BLAD.</p><p><strong>Methods: </strong>In this retrospective cohort study, we analyzed adult first-time double-lung transplant recipients (12/2017-10/2021) who had 12-month CT chest and concurrent BLAD/non-BLAD status assigned. Three radiologists used a semi-quantitative ordinal score to evaluate ground glass opacities (GGO), reticulation, consolidation, pleural effusion, bronchiectasis, and air-trapping. Machine learning-trained lung texture analysis provided CT radiomic data: CT-measured total lung capacity (CT<sub>TLC</sub>), pulmonary vessel volume (PVV), GGO, reticulation, and hyperlucency. Parametric response mapping measured functional small airways disease. Receiver operating characteristic analysis and logistic regression identified radiologic features of BLAD.</p><p><strong>Results: </strong>BLAD patients (n = 59, 46%) had longer intubation duration, longer index hospitalization post-transplant, and lower donor-to-recipient total lung capacity (TLC) ratio than non-BLAD patients (n = 69, 54%). Radiologist-assessed scoring identified more pleural effusions in BLAD with no significant differences in GGO or air trapping. Computer-aided CT demonstrated more reticulation, GGO, and parenchymal density in BLAD, with no difference in functional small airways disease. CT<sub>TLC</sub> indexed for height was lower in BLAD, while PVV was higher. PVV was significantly associated with BLAD in univariable analysis (OR 2.30, 95% CI 1.38-3.83, p < 0.001), and remained strong after adjusting for age, sex, and native disease (OR = 2.65,95% CI 1.45-4.84, p = 0.002).</p><p><strong>Conclusions: </strong>Computer-aided CT elicited structural changes in BLAD not captured by limited-slice radiologist review. CT<sub>TLC</sub> and PVV were the strongest radiologic predictors of BLAD, likely reflecting restrictive physiology and vascular remodeling.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145889232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: Impact of right ventricular reserve during exercise on aortic valve opening in patients with a left ventricular assist device. 致编辑:运动时右心室储备对左心室辅助装置患者主动脉瓣开度的影响。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-22 DOI: 10.1016/j.healun.2025.11.033
Veraprapas Kittipibul, Jason N Katz
{"title":"Letter to the editor: Impact of right ventricular reserve during exercise on aortic valve opening in patients with a left ventricular assist device.","authors":"Veraprapas Kittipibul, Jason N Katz","doi":"10.1016/j.healun.2025.11.033","DOIUrl":"https://doi.org/10.1016/j.healun.2025.11.033","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement 肺移植临床试验终点的考虑:一项ISHLT共识声明。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-16 DOI: 10.1016/j.healun.2025.09.017
John R. Greenland MD, PhD , Michael Perch MD , Kieran Halloran MD, MSc , Deborah J. Levine MD , Eric D. Morrell MD, MA , Anna Reed MBChB , Ciara M. Shaver MD, PhD , Jonathan P. Singer MD, MS , Stuart C. Sweet MD, PhD , Robin Vos MD, PhD , Shambhu Aryal MD, FCCP , Nicholas Avdimiretz MD, FRCPC , Fay Burrows BPharm , Daniel Calabrese MD , Fiorella Calabrese MD , Silvia Campos PhD , Michael Combs MD, MS , Marc de Perrot MD, MSc, FRCSC , Göran Dellgren MD, PhD , Joshua M. Diamond MD, MS , Jamie L. Todd MD, MHS
Clinical trials in lung transplantation have been hindered by a lack of clarity on the formulation and significance of endpoints for evaluating therapeutic efficacy. To address this challenge, a multidisciplinary working group from the International Society for Heart and Lung Transplantation developed consensus recommendations on endpoints beyond mortality. These endpoints include primary graft dysfunction (PGD), chronic lung allograft dysfunction (CLAD), acute cellular rejection (ACR), antibody-mediated rejection (AMR), immunosuppression-related complications, patient-reported outcomes (PROs), and pediatric-specific considerations. For each endpoint, a subgroup reviewed measurement best practices, assessed links to clinical benefit, and evaluated the evidence supporting their utility in clinical trial settings. Consensus was established through a Delphi process involving three rounds of voting. This document provides practical guidance for operationalizing these endpoints and outlines their optimal use in clinical trials. By standardizing trial design, these recommendations aim to accelerate the development of urgently needed therapies to improve lung transplantation outcomes.
肺移植的临床试验一直受阻于缺乏明确的配方和终点的重要性,以评估治疗效果。为了应对这一挑战,国际心肺移植学会的一个多学科工作组就死亡率以外的终点提出了共识建议。这些终点包括原发性移植物功能障碍(PGD)、慢性同种异体肺移植物功能障碍(CLAD)、急性细胞排斥反应(ACR)、抗体介导的排斥反应(AMR)、免疫抑制相关并发症、患者报告的结局(PROs)和儿科特异性考虑。对于每个终点,一个亚组回顾了测量最佳实践,评估了与临床获益的联系,并评估了支持其在临床试验环境中的效用的证据。通过涉及三轮投票的德尔菲程序建立了协商一致意见。本文档为这些终点的操作提供了实用指导,并概述了它们在临床试验中的最佳使用。通过标准化试验设计,这些建议旨在加速开发急需的治疗方法,以改善肺移植的结果。
{"title":"Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement","authors":"John R. Greenland MD, PhD ,&nbsp;Michael Perch MD ,&nbsp;Kieran Halloran MD, MSc ,&nbsp;Deborah J. Levine MD ,&nbsp;Eric D. Morrell MD, MA ,&nbsp;Anna Reed MBChB ,&nbsp;Ciara M. Shaver MD, PhD ,&nbsp;Jonathan P. Singer MD, MS ,&nbsp;Stuart C. Sweet MD, PhD ,&nbsp;Robin Vos MD, PhD ,&nbsp;Shambhu Aryal MD, FCCP ,&nbsp;Nicholas Avdimiretz MD, FRCPC ,&nbsp;Fay Burrows BPharm ,&nbsp;Daniel Calabrese MD ,&nbsp;Fiorella Calabrese MD ,&nbsp;Silvia Campos PhD ,&nbsp;Michael Combs MD, MS ,&nbsp;Marc de Perrot MD, MSc, FRCSC ,&nbsp;Göran Dellgren MD, PhD ,&nbsp;Joshua M. Diamond MD, MS ,&nbsp;Jamie L. Todd MD, MHS","doi":"10.1016/j.healun.2025.09.017","DOIUrl":"10.1016/j.healun.2025.09.017","url":null,"abstract":"<div><div>Clinical trials in lung transplantation have been hindered by a lack of clarity on the formulation and significance of endpoints for evaluating therapeutic efficacy. To address this challenge, a multidisciplinary working group from the International Society for Heart and Lung Transplantation developed consensus recommendations on endpoints beyond mortality. These endpoints include primary graft dysfunction (PGD), chronic lung allograft dysfunction (CLAD), acute cellular rejection (ACR), antibody-mediated rejection (AMR), immunosuppression-related complications, patient-reported outcomes (PROs), and pediatric-specific considerations. For each endpoint, a subgroup reviewed measurement best practices, assessed links to clinical benefit, and evaluated the evidence supporting their utility in clinical trial settings. Consensus was established through a Delphi process involving three rounds of voting. This document provides practical guidance for operationalizing these endpoints and outlines their optimal use in clinical trials. By standardizing trial design, these recommendations aim to accelerate the development of urgently needed therapies to improve lung transplantation outcomes.</div></div>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":"45 2","pages":"Pages e104-e128"},"PeriodicalIF":6.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者资讯
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-13 DOI: 10.1016/S1053-2498(25)02445-3
{"title":"Information for Readers","authors":"","doi":"10.1016/S1053-2498(25)02445-3","DOIUrl":"10.1016/S1053-2498(25)02445-3","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":"45 1","pages":"Page A2"},"PeriodicalIF":6.0,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145731065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Insights on the ISHLT Perioperative Utilization of ECLS In Lung Transplantation Consensus 作者对肝移植围手术期ECLS应用的见解共识
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-13 DOI: 10.1016/j.healun.2025.11.008
Archer Kilbourne Martin MD , Olaf Mercier MD, PhD , Brandi Bottiger MD , Marcelo Cypel MD, PhD , Julien Fessler MD , David Gomez-De-Antonio MD , Bronwyn Levvey PhD , Haifa Lyster PhD , Basil Nasir MD , Melissa Sanchez DClinPsy , Keith Wille MD , Ashley Virginia Fritz DO , Theresa Gelzinis MD , Konrad Hoetzenecker MD, PhD , Kavita Dave MD , Sandra Lindstedt MD, PhD , Nandor Marczin MD, PhD , Barbara Wilkey MD , Marc Schecter MD , James Walsh PhD , Anna K. Reed MD, PhD
The International Society for Heart and Lung Transplantation Consensus for Perioperative Utilization of Extracorporeal Life Support in Lung Transplantation consists of 111 Delphi-derived statements across 3 separate manuscripts. These statements aim to provide comprehensive phase-of-care recommendations for international multidisciplinary teams to use in their clinical practice from time of recipient waitlisting to six-months post-hospital discharge. In this article, the multidisciplinary author group provides an abbreviated high-level summary of the consensus for the journal reader.
国际心肺移植学会关于肺移植围手术期使用体外生命支持的共识包括111份德尔菲衍生的声明,横跨3份独立的手稿。这些声明旨在为国际多学科团队提供全面的护理阶段建议,以便在从接受者等待名单到出院后六个月的临床实践中使用。在这篇文章中,多学科作者小组为期刊读者提供了一个简短的高层次的共识摘要。
{"title":"Author Insights on the ISHLT Perioperative Utilization of ECLS In Lung Transplantation Consensus","authors":"Archer Kilbourne Martin MD ,&nbsp;Olaf Mercier MD, PhD ,&nbsp;Brandi Bottiger MD ,&nbsp;Marcelo Cypel MD, PhD ,&nbsp;Julien Fessler MD ,&nbsp;David Gomez-De-Antonio MD ,&nbsp;Bronwyn Levvey PhD ,&nbsp;Haifa Lyster PhD ,&nbsp;Basil Nasir MD ,&nbsp;Melissa Sanchez DClinPsy ,&nbsp;Keith Wille MD ,&nbsp;Ashley Virginia Fritz DO ,&nbsp;Theresa Gelzinis MD ,&nbsp;Konrad Hoetzenecker MD, PhD ,&nbsp;Kavita Dave MD ,&nbsp;Sandra Lindstedt MD, PhD ,&nbsp;Nandor Marczin MD, PhD ,&nbsp;Barbara Wilkey MD ,&nbsp;Marc Schecter MD ,&nbsp;James Walsh PhD ,&nbsp;Anna K. Reed MD, PhD","doi":"10.1016/j.healun.2025.11.008","DOIUrl":"10.1016/j.healun.2025.11.008","url":null,"abstract":"<div><div>The International Society for Heart and Lung Transplantation Consensus for Perioperative Utilization of Extracorporeal Life Support in Lung Transplantation consists of 111 Delphi-derived statements across 3 separate manuscripts. These statements aim to provide comprehensive phase-of-care recommendations for international multidisciplinary teams to use in their clinical practice from time of recipient waitlisting to six-months post-hospital discharge. In this article, the multidisciplinary author group provides an abbreviated high-level summary of the consensus for the journal reader.</div></div>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":"45 1","pages":"Pages 1-4"},"PeriodicalIF":6.0,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145731064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invited response letter. 邀请回应函。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-04 DOI: 10.1016/j.healun.2025.11.025
Alexander R Berg, Aravind Krishnan, Elbert E Heng, Ashley Y Choi, Alyssa C Garrison, Daniel I Alnasir, Y Chawannuch Ruaengsri, Yasuhiro Shudo, Y Joseph Woo, John W MacArthur
{"title":"Invited response letter.","authors":"Alexander R Berg, Aravind Krishnan, Elbert E Heng, Ashley Y Choi, Alyssa C Garrison, Daniel I Alnasir, Y Chawannuch Ruaengsri, Yasuhiro Shudo, Y Joseph Woo, John W MacArthur","doi":"10.1016/j.healun.2025.11.025","DOIUrl":"10.1016/j.healun.2025.11.025","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145687686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ex-vivo heart perfusion in agonal periods greater than 30 min: Interpretation requires caution. 离体心脏灌注大于30分钟:解释需要谨慎。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-04 DOI: 10.1016/j.healun.2025.11.016
Aaron M Williams, Swaroop Bommareddi, John M Trahanas, Awab Ahmad, Ashish S Shah, Brian Lima
{"title":"Ex-vivo heart perfusion in agonal periods greater than 30 min: Interpretation requires caution.","authors":"Aaron M Williams, Swaroop Bommareddi, John M Trahanas, Awab Ahmad, Ashish S Shah, Brian Lima","doi":"10.1016/j.healun.2025.11.016","DOIUrl":"https://doi.org/10.1016/j.healun.2025.11.016","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The devil is in the details of Donation after Circulatory Death lung transplantation. 关键在于循环死亡后肺移植捐献的细节。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-03 DOI: 10.1016/j.healun.2025.11.021
Gregory I Snell, Bronwyn J Levvey
{"title":"The devil is in the details of Donation after Circulatory Death lung transplantation.","authors":"Gregory I Snell, Bronwyn J Levvey","doi":"10.1016/j.healun.2025.11.021","DOIUrl":"https://doi.org/10.1016/j.healun.2025.11.021","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments and opinions regarding “A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors” by Ware LB et al. 关于Ware LB等人的“一项在死亡器官供者中进行开放式肺保护性通气与常规机械通气的随机试验”的评论和意见。
IF 6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-21 DOI: 10.1016/j.healun.2025.07.030
Parth Aphale PhD , Himanshu Shekhar , Shashank Dokania
{"title":"Comments and opinions regarding “A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors” by Ware LB et al.","authors":"Parth Aphale PhD ,&nbsp;Himanshu Shekhar ,&nbsp;Shashank Dokania","doi":"10.1016/j.healun.2025.07.030","DOIUrl":"10.1016/j.healun.2025.07.030","url":null,"abstract":"","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":"44 12","pages":"Pages 2042-2043"},"PeriodicalIF":6.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145555095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Heart and Lung Transplantation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1